Skip to content
Screener

Kiniksa Pharmaceuticals International, plc KNSA Q1 2026 earnings

Reported April 28, 2026 · Before market open

Revenue$214.3MBeat by $8.2M
EPS$0.27Beat by $0.09
Revenue estimate$206.1M
EPS estimate$0.18

Next report

Oct 27, 2026 (in 3 months)
Revenue estimate$256.7M
EPS estimate$0.36

Financials

Q1 2026

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$3.69B+128%
Enterprise value$3.5B+139%
P/E50.4×—
P/S4.9×+1.5×

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×
Current ratio3.8×+0.1×

Segments

By segment

See full
Pharmaceutical$214.3M+55.5%

By product

See full
Collaboration-—

FAQ

When did Kiniksa Pharmaceuticals International, plc report Q1 2026 earnings?
Kiniksa Pharmaceuticals International, plc (KNSA) reported Q1 2026 earnings on April 28, 2026 before market open.
What were Kiniksa Pharmaceuticals International, plc's Q1 2026 revenue and EPS?
Kiniksa Pharmaceuticals International, plc reported revenue of $214.3M and eps of $0.27 for Q1 2026.
Did Kiniksa Pharmaceuticals International, plc beat estimates in Q1 2026?
Revenue beat the consensus estimate of $206.1M by $8.2M. EPS beat the consensus estimate of $0.18 by $0.09.
How did Kiniksa Pharmaceuticals International, plc's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 55.5% from $137.8M a year earlier and eps grew 145.5% from $0.11.
Where can I find Kiniksa Pharmaceuticals International, plc's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001730430-26-000017) and the 10-Q periodic report (0001104659-26-050359) directly on SEC EDGAR. The filing index links above go to sec.gov.